Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
Is there any reason to stop mesalamine in a patient with UC undergoing breast/regional nodal radiation?
Answer from: Radiation Oncologist at Academic Institution
I have run into this situation a few times and have not stopped mesalamine during breast radiation. Have not noticed any issues.
Sign in or Register to read more
11392
Related Questions
Would you recommend MRI post surgery and pre-irradiation for patients with extensive DCIS and close margins and how would it impact your management?
What is the earliest you would start postmastectomy radiation after adjuvant chemotherapy for a patient with breast cancer?
In the setting of recurrent breast cancer localized to the chest wall (no prior RT), do you allow concurrent abemaciclib or Enhertu with post-operative comprehensive chest wall irradiation?
When should the dissected axilla (levels I-II) be included when delivering RNI?
Do you offer APBI to patients who do not have surgical clips but a visible seroma?
Would you recommend PMRT for multifocal IDC with extensive LVI and 1 SLN with ITCs?
How would you manage a patient presenting with recurrent cT4 breast cancer?
When doing a tumor bed boost following whole breast irradiation, what do you typically use for CTV and PTV margin for photon and electron plans?
What is your approach to a tumor bed boost in early stage breast cancer patients with micrometastasis?
Are there additional risks associated with PMRT for a patient with prior lympho-venous bypass surgery?